The Significance of Whole-body MRI in Prostate Cancer Treatment

Hiromichi Iwamura

Whole-body MRI; how to introduce and use in high-volume centers and university hospitals

Kotaro Yoshida

Utility of PSMA-PET to revolutionize the treatment of prostate cancer

Tadashi Watabe

Initial experience of PSMA radioligand therapy for Japanese CRPC patients.

Kenta Miki

The Impact of Next Generation Imaging Modalities on Prostate Cancer Treatment

Soichiro Yoshida

Local and metastasis-directed therapy for patients with metastatic prostate cancer: Global trends from the report of the APCCC

Takanobu Utsumi

Local therapy and metastasis directed therapy for patients with metastatic prostate cancer; present outcomes and future perspectives in Japan

Naoki Terada

Local and metastasis-directed radiation therapy for metastatic prostate cancer

Rihito Aizawa

Local therapy for primary and metastatic lesions in metastatic prostate cancer: treatment strategies and case discussions from a urologist's perspective

Soichiro Yoshida

How to use chemotherapy after doublet/triplet treatment

Takeo Kosaka

To whom and when do we apply the cancer genome precision medicine for mCRPC after upfront hormonal therapy (doublet/triplet therapy)?

Takahiro Inoue

New Treatment Development and Future Prospects after Doublet/Triplet Treatment

Masaki Shiota

Initial treatment strategy for mCSPC in anticipation of future mCRPC treatment

Takuma Katou

今こそmCSPCにおけるVintage治療の価値を明らかにする ～個別化治療に向けて～

片山 聡

必要十分を目指すmCSPC治療

中島 裕理

リアルワールドから見えてくるmCSPC治療におけるvingateと2G-ARSIの実相

泉 浩二

Upfront ARSIの適応と限界～積極的にupfront ARSIを行ってきた立場から～

成田 伸太郎

mCSPC患者個々の病態と患者の生活信条に見合った薬物療法を

武内 務

Focal therapy with high-intensity focused ultrasound for the patients with localized prostate cancer: a multi-institutional prospective study in Japan

Sunao Shoji

Development of Nerve-Sparing Surgical Technique Using ICG Fluorescence Navigation System in Robot-Assisted Radical Prostatectomy

Naotaka Gunge

Targeted pelvic lymph node dissection using tumor-targeted Indocyanine green injection assisted by Magnetic Resonance Imaging - Ultrasonography fusion technique

Yuuta Yamada

Automated surgical process recognition using artificial Intelligence and external validity verification in robot-assisted radical prostatectomy

Yuichiro Konnai

Clinical workflow of lesion targeted focal therapy for localized prostate cancer

Atsuko Fujihara

Targeting homologous recombination repair pathway in prostate cancer

Shusuke Akamatsu

Prostate cancer screening; developments and opportunities

Roderick Van Den Bergh

Best practice in low volume mHSPC/oligometastatic disease: surgery or systemic therapy?

Igor Tsaur

Metastatic Prostate Cancer: Navigating the Spectrum from mHSPC to mCRPC

Axel Merseburger

Gene mutation analysis of bladder cancer after radiotherapy for prostate cancer

Shogo Adomi

Genome-wide CRISPR screens identified DCLRE1C which regulates prostate cancer sensitivity to radiation therapy

Toshiki Oka

Loss of function of histone modifier UTX contributes to prostate cancer development through promoting inflammation and impairing DNA damage repair

Nobuhito Muramoto

BRD4/Myc targeted therapy overcomes CDDP resistance in NEUROD1-positive NEPC

Yota Yasumizu

FGF-KRAS signaling promotes the progression of double negative prostate cancer

Taiki Kamijima

Establishment and application of organoids derived from patient-derived xenografts(PDX) of castration resistant prostate cancer(CRPC)

Takuro Sunada

Heterogeneity of PSMA expression and development of novel therapeutic approach for PSMA-targeted therapy unfit tumors in advanced prostate cancer

Yasutaka Yamada

Endothelial-mesenchymal transition in the tumor microenvironment promotes neuroendocrine differentiation of prostate cancer

Takumi Kageyama

Expanding the Therapeutic Potential of PARP Inhibition: Insights from a Genome-Wide CRISPR/Cas9 Screen in Prostate Cancer Cells

Ko Nakamura

Investigating the relationship between prostate cancer, colorectal cancer, and ulcerative colitis

Yurie Kura

The possible role of gene body methylation of ONECUT2 in its transcriptional regulation and biomarker in prostate cancer

Yohei Sekino

Polygenetic risk score for prostate cancer is associated with lipopolysaccharide pathway in gut microbiome

Koji Hatano

Spatial transcriptomics reveal intra-tumor heterogeneity and niche factors in AR-indifferent prostate cancer

Yuto Baba

Clinical outcomes of de novo metastatic castration-sensitive prostate cancer patients with lung metastases

Takayuki Sumiyoshi

Margin assessment in focal therapy for prostate cancer: Analysis of distance between target outline and perilesional positive cores using MRI/US fusion biopsy

Hiromi Uno

Evaluation of the predictive ability of TP53 gene mutation by immunohistochemistry in Japanese patients with ductal adenocarcinoma of the prostate

Hiroaki Kobayashi

Characteristics of the alpha 2,3-sialyl N-glycosylated PSA as a biomarker for prostate cancer in men with grey zone levels of the PSA

Hayato Yamamoto

Phi could be a promising biomarker to reduce unnecessary biopsy for prostate cancer

Mitsuru Kajiwara

Phase I/IIa Trial of 18F-Prostate Specific Membrane Antigen (PSMA) PET/CT in Healthy Volunteers and Prostate Cancer Patients

Soichiro Yoshida

Deep learning model for predicting significant prostate cancer; can we bypass prostate biopsy prior to the curative treatment?

Takahiko Soma

Utility of combining prostate health index and MRI in diagnosing prostate cancer

Yoshitaka Sekine

Preliminary evidence for developing safety and clinical efficiency of luteolin treatment in prostate cancer

Taku Naiki

Prostate cancer harboring low COMT expression correlates with a poor prognosis and response to enzalutamide

Shigekatsu Maekawa

Long-term outcomes of a multicenter prospective observational study of active surveillance for early-stage prostate cancer: the PRIAS-JAPAN study

Takuma Katou

Comparison of QOL between enzalutamide and abiraterone plus prednisolone for CRPC: ENABLE study for PCa sub-analysis

Kouji Izumi

Results and trends of cancer genome profiling tests for prostate cancer in Japan

Yusuke Sato

The impact of local radiotherapy on the prognosis of patients with locally advanced and metastatic castration-sensitive prostate cancer: the LORTIP trial

Kouhei Hashimoto

Real-World survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for non-metastatic castration-resistant prostate cancer

Takuya Tsujino

Comparative long-term outcomes of monotherapy vs. combined hormone therapy in favorable intermediate-risk prostate cancer treated with carbon Ion radiotherapy

Masahiro Onishi

Impact of cribriform pattern 4 carcinoma/intraductal carcinoma of the prostate (CC/IDCP) on persistent PSA after robot-assisted radical prostatectomy (RARP)

Takeshi Sasaki

Prognostic importance of lymphovascular invasion for specific subgroup of patients with prostate cancer after robot-assisted radical prostatectomy(MSUG94 group)

Makoto Kawase

Clinical outcomes of second-Line therapy after androgen receptor-axis-targeted treatment for metastatic hormone-sensitive prostate cancer

Kotaro Suzuki

The outcome of upfront ARAT for metastatic hormone-sensitive prostate cancer in Fukui

Minekatsu Taga

Reducing Early Side Effects through Introduction of a Treatment Algorithm for Metastatic Hormone-Sensitive Prostate Cancer

Kento Morozumi

Upfront treatment of metastatic hormone-sensitive prostate cancer real world date

Hikari Miura

Comparison of efficacy of apalutamide with that of bicalutamide for patients with metastatic hormone-sensitive prostate cancer

Takashi Ueda

Early PSA reduction after the initiation of Enzalutamide treatment predicts overall survival in castration resistant prostate

Yutong Liu

Current status of sequential treatment for castration-resistant prostate cancer at Showa University hospital

Toshiki Mugita

Clinical outcome of chemotherapy in 22 prostate cancer patients with neuroendocrine differentiation

Tomoaki Terakawa

Prognostic and predictive factor analysis using machine learning analysis in metastatic prostate cancer: the JUOG multicentre study

Shinichi Sakamoto

Do androgen receptor axis-targeted agents improve metastatic hormone-sensitive prostate cancer outcomes than combined androgen blockade therapy in elderly?

Nami Tomiyama

Examination of treatment strategies for patients with low risk metastatic castration-sensitive prostate cancer

Hiroaki Iwamoto

Retrospective analysis of upfront therapy for metastatic hormone sensitive prostate cancer

Shoko Ishikawa

Comparison of upfront ARAT and CAB outcomes for metastatic castration-sensitive prostate cancer at our institution

Michio Noda

Optimal PSA threshold for the non-metastatic castration resistant prostate cancer (nmCRPC) definition

Kazuhiro Matsumoto

Treatment efficacy of docetaxel in metastatic castration-resistant prostate cancer since the introduction of androgen receptor axis-targeted therapy agents

Takahiro Yamaguchi

Re-evaluating the current efficacy and optimal therapeutic positioning of docetaxel for castration-resistant prostate cancer

Katsuaki Chikui

Initial Experience with Carboplatin-Paclitaxel Therapy for Metastatic Castration-resistant Prostate Cancer Refractory to Standard Chemotherapy

Wataru Nakamura

Real world treatment patterns and resource utilization among patients with metastatic hormone-sensitive prostate cancer (mHSPC): a retrospective study in Japan

Takahiro Kimura

Can PSA F/T ratio or PSAD be an aid for prostate cancer diagnosis using MRI?

Noboru Sakamoto

The efficacy of MRI as a screening modality for detecting clinically significant prostate cancer

Keina Nozaki

Cancer board for localized prostate cancer

Atsuko Fujihara

Initial Experience of Companion Diagnostic Test for Metastatic Castration-Resistant Prostate Cancer

Taisuke Matsue

BRCA companion diagnosis and olaparib treatment results in metastatic castration-resistant prostate cancer

Kojiro Tashiro

Examination of the usefulness of preoperative urine cytology for detecting prostate cancer with IDC-P

Sho Yamagiwa

Molecular Profiling of Bone Marrow Neutrophil Immune Response to Bone Metastatic Prostate Cancer Cells

Kosuke Nakano

DNA-Methylation profiles: A Novel Method to Identify Aggressive Prostate Cancer from Needle core Biopsy

Masatomo Kaneko

J C Polyomavirus-like Particles Carrying Suicide Genes Effectively Inhibit Orthotopic mCRPC Tumor Growth and Metastasis in Mice

Shen Cheng Huang

A highly-sensitive screening system to evaluate the reversibility of lineage plasticity in NEPC using a novel NEPC cell line

Tomohiro Fukui

Chemopreventive effects of rutin on prostate carcinogenesis

Maria Aoki

Predictive Ability of Lesion Localization Using Real-time 3D MRI/ultrasound Fusion Prostate Biopsy in Robot-assisted Laparoscopic Prostatectomy

Yukari Bando

A diagnostic significance of prostate health index (phi)-MRI sequence flow in patients with PSA below 10 ng/ml

Kazuto Itou

多様化する前立腺がんの遺伝子検査：個別化医療への道

池田 貞勝

Real-world Comparison of ARAT in mCRPC: Taiwan National Health Database Analysis

See-Tong Pang

Role of MRI in Active Surveillance of Prostate Cancer

Jun Hyuk Hong

Advanced Prostate Cancer: Current Research and Future Directions

Axel Merseburger

mCSPCに対するdoublet/triplet therapy

杉元 幹史

Automated detection of clinically significant prostate cancer using a novel biparametric MRI based machine learning system

Masatomo Kaneko

Green learning: a transparent machine learning model for automated classification of clinically significant prostate cancer confirmed on MRI target biopsy

Masatomo Kaneko

Investigation of the association between pathological grade and heart rate variability in prostate cancer using wearable heart rate sensor

Yoshihiro Ikehata

Longitudinal Changes of Metastatic Organs in Fatal Prostate, Kidney, and Bladder Cancers: Analysis of Japanese Autopsy Registry

Suguru Oka

Long-term results of prostatectomy for rectal invasion of prostate cancer

Kenji Numahata

Muscle mass according to treatment methods in prostate cancer patients

Akihiro Kosoku

Enhancing clinical decision-making: the role of additional therapy for postprostatectomy prostate cancer patients

Tomoyuki Shimabukuro

Association between pathologic findings of surgery and biochemical prognosis for prostate cancer; A retrospective, single-institutional study

Shogo Watari

Focal Cryoablation and HIFU for Intermediate Risk Prostate Cancer: Multi-center Medium-term Follow-up Outcomes

Masatomo Kaneko

Comparison of oncological outcome and quality of life between radical prostatectomy and low-dose-rate brachytherapy in patients with high-risk prostate cancer

Yasushi Nakai

The analysis of a treatment outcome of Iodine-125 permanent prostate seed implantation for prostate cancer at our hospital.

Takuhisa Nukaya

Clinical outcomes of trimodality therapy in patients with high-risk localized prostate cancer

Tomoharu Fukumori

Comparison between long-term outcomes of low-dose-rate brachytherapy and radical prostatectomy in patients with intermediate-risk prostate cancer

Katsuki Muramoto

Long-term outcomes of high-dose-rate brachytherapy with external beam radiotherapy for localized and locally advanced prostate cancer

Tomoyuki Makino

The Clinical Outcomes of Combining Prostate-Directed Radiotherapy and Metastasis-Directed Radiotherapy in De Novo Oligometastatic Prostate Cancer

Hideyasu Tsumura

The efficacy of metastasis-directed external beam radiotherapy for castration-resistant prostate cancer. A retrospective multicenter study.

Yasuyuki Sakai

Initial experience of focal re-irradiation with MRIdian Linac system for local recurrence after IMRT for prostate cancer

Fumio Tsukuda

Secondary bladder cancer and late toxicity after intensity-modulated radiotherapy for prostate cancer

Kazuhiro Watanabe

Efficacy of moderately hypofractionated radiotherapy for prostate cancer

Shu Nakasuka

Secondary bladder cancers after radiotherapy and radical prostatectomy for the treatment of prostate cancer

Hideyuki Terao

Effect of hypofractionated proton therapy for prostate cancer on the lower urinary tract function

Takashi Hamakawa

The impact of separated distance of hydrogel spacer at prostate-apex level on proton beam therapy for prostate cancer

Tsukasa Narukawa

Carbon-ion radiotherapy for prostate cancer in Gunma University Heavy Ion Medical Center

Hiroshi Matsui

Clinical outcomes of HDR brachytherapy for localized prostate cancer: from three fractions two days with EBRT to single fraction monotherapy

Shingo Ashida

The evaluation of the proper timing of stopping PSA monitoring after high-dose-rate brachytherapy in prostate cancer patients

Minoru Nakazono

Experience of PSMA radioligand therapy in Japanese patients with metastatic castration-resistant prostate cancer

Hidetoshi Kuruma

The role of myoferlin in vesicle trafficking and the effects of its overexpression in prostate cancer

Yuki Katsumata

Exploration of novel prognostic factors for biochemical recurrence prostate cancer using formalin-fixed paraffin-embedded radical prostatectomy samples

Hikaru Mikami

Prostate cancer cells educate malignant osteoclasts and accelerate bone invasion via communication networks with extracellular vesicles

Takaaki Tamura

Profiling myeloid-derived suppressor cells during prostate cancer progression

Marco Develasco

Immunosuppressive myeloid cells drive prostate cancer immune suppression via extracellular adenosine

Marco Develasco

Radioresistant prostate cancer forms a hypoxic environment and 5-aminolevulinic acid improves radiosensitivity

Fumisato Maesaka

Search for prostate index cancer markers using DNA methylation as an indicator

Satoshi Sako

Advance Care Planning and Palliative Home Care for Patients with Advanced Prostate Cancer

Satoshi Yazawa

Functional and oncologic prognosis of RARP for prostate cancer diagnosed by MRI-US fusion biopsy

Kazumi Kamoi

Validation of neurovascular bundle preservation criteria for robot-assisted laparoscopic radical prostatectomy for prostate cancer

Toshihide Hosomi

Unemployment Affects Patient’s Choice of Adjuvant/Salvage Therapy after Radical Prostatectomy

Seolho Choo

An exploratory clinical trial of nerve sheets using alginate gel combined with polyglycolic acid for recovery of erectile function after radical prostatectomy

Shintarou Narita

Ex-vivo Fluorescence Confocal Microscopy for PSM Diagnosis during RARP: A Proof-of-Concept Study

Greg L Shaw

RARP using hinotori surgical robot system: Docking-free design may contribute to the reduction of postoperative pain

Yutaro Sasaki

Complete Urethral Preservation during Robotic Radical Prostatectomy, technique and early outcomes

Greg L Shaw

Salvage robot-assisted surgery after carbon ion radiotherapy to the prostate cancer

Shigehiro Tsukahara

Robot-Assisted MRI-Ultrasound Prostate Fusion Biopsy: Outcomes and Experiences at a Tertiary Center

Chih-Kai Peng

Development and validation of nomograms for predicting pentafecta outcomes before and after robot-assisted radical prostatectomy

Kiyoshi Takahara

Integrative gut microbiome analysis of human and mouse prostate cancer

Marco Develasco

Genome-wide CRISPR/Cas9 Screens Reveal Key Modulators of ATR Inhibition Response in Prostate Cancer

Shoko Kinoshita

Treatment strategy for locally advanced prostate cancer ~the role of RARP~

Noriyoshi Miura

The treatment strategy for locally advanced prostate cancer

Yosuke Hirasawa

Current status and future prospects of external beam radiation therapy for locally advanced prostate cancer

Takashi Mizowaki

High-dose-rate brachytherapy and additional external-beam radiotherapy combined with long-term androgen deprivation therapy for high-risk prostate cancer

Takahiro Kimura

Epigenetics and liquid-liquid phase separation analyses reveal new roles of transcription factors in prostate cancer progression

Satoshi Inoue

mCRPCに対するアビラテロン＋オラパリブ

杉元 幹史

mCSPCに対するtriplet therapy

赤松 秀輔

Evaluation of the usefulness of prostate health index as diagnostic marker of prostate cancer

Seiji Nagasawa

Examination of factors that improve prostate cancer detection rate of PI-RADS4 lesions in transition zone

Yu Imai

Treatment patterns and outcomes of elderly high-risk metastatic hormone-naïve prostate cancer patients: Results from interim analysis 2 of J-ROCK study

Hideyasu Matsuyama

Treatment efficacy of darolutamide-containing triplet therapy in metastatic hormone-sensitive prostate cancer

Takahiro Oguchi

Patient experience with Ra-223 treatment: satisfaction, anxiety and quality of life in metastatic castration resistant prostate cancer (mCRPC) in Japan

Hiroji Uemura

Clinical outcomes of ultra-hypofractionated radiotherapy with SpaceOAR Hydrogel Spacer for prostate cancer

Ibuki Sadakane

Outcomes of open radical prostatectomy for gleason grade group 5 prostate cancer

Satoshi Hamano

Total prostatectomy in a patient with metastatic castration-sensitive prostate cancer

Naoki Ueda

Clinical outcomes of cytoreductive prostatectomy in patients with castration-resistant prostate cancer

Kenichiro Fukuoka

The usefulness of transrectal ultrasound findings to detect significant prostate cancer in MRI/TRUS fusion image-guided targeted biopsy

Masaya Itou

Impact of ultrasonographic findings of index lesion by multiparametric magnetic resonance imaging on prostate cancer detection rate

Masakazu Abe

Whole-body MRI is a powerful imaging modality to identify progressing foci suitable for comprehensive genomic profiling tissue acquisition in mCRPC patients

Sachi Kitayama

Clinical utility of Prostate health index(phi) in prostate cancer diagnosis in patients with negative MRI findings

Kazuhiko Oshinomi

A retrospective comparative study of overall survival from mCRPC diagnosis between synchronous and metachronous metastatic prostate cancer patients

Koichi Uemura

The usefulness of [-2] proPSA-related index in prostate cancer diagnosis

Yuka Toyama

The widespread of pre-biopsy MRI contributes to improved detection of clinically significant prostate cancer: Single-institution 10-year retrospective study

Hiroshi Shimura

Genomic characterization of metastatic patterns by circulating tumor DNA in prostate cancer: SCRUM-Japan MONSTAR SCREEN project

Masaki Shiota

Current use of prostate cancer oncogene panel examinations at Nagasaki University Hospital

Yuichiro Nakamura

Genomic analysis and immunohistological validation of RB1 and p53 mutations in treatment-related neuroendocrine prostate cancer

Hideto Ueki

Pre-publication monitoring of Clinical Practice Guidelines for Prostate Cancer 2023

Yasuo Kohjimoto

Changes in bladder outlet obstruction by combined androgen blockade against high-risk prostate cancer

Yuki Kyoda

The efficacy and safety of neoadjuvant hormonal therapy with Estramustine phosphate and Degarelix for locally advanced prostate cancer

Seiichi Kato

The outcome of androgen receptor signaling inhibitor therapies for metastatic hormone-sensitive prostate cancer at Yamaguchi University

Takanori Tokunaga

Real-world PSA response and progression to CRPC among men with metastatic CSPC treated with apalutamide

Yoichiro Tohi

Effect of sequential therapy for metastatic castration-resistant prostate cancer following up-front androgen receptor pathway inhibitors

Yushi Naito

Comparative study of the therapeutic efficacy of apalutamide and enzalutamide in metastatic hormone-sensitive prostate cancer

Yusuke Gabata

Significance of the upfront treatment for mHSPC patient over 80 years old

Jotaro Mikami

Prognosis of metastatic castration-resistant prostate cancer(mCRPC) in the era of upfront therapy

Hideji Kawanishi

Prospective observational study of castration-resistant prostate cancer with homologous recombination repair-related gene mutations (HRRCAP study)

Takayuki Goto

Efficacy and Safety of Enzalutamide, Apalutamide and Darolutamide in the Treatment of Patients with nmCRPC: A retrospective analysis

Shuhei Hara

Flare Phenomenon in Bone Scintigraphy Is a Prognostic Factor in Patients with High- Volume mCRPC Treated with Docetaxel

Atsushi Mizokami